These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 25261428

  • 1. Toxicology and management of novel psychoactive drugs.
    Kersten BP, McLaughlin ME.
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [Abstract] [Full Text] [Related]

  • 2. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M, Mondola R.
    Toxicol Lett; 2012 Jun 01; 211(2):144-9. PubMed ID: 22459606
    [Abstract] [Full Text] [Related]

  • 3. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
    Dargan PI, Sedefov R, Gallegos A, Wood DM.
    Drug Test Anal; 2011 Jun 01; 3(7-8):454-63. PubMed ID: 21755604
    [Abstract] [Full Text] [Related]

  • 4. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M.
    Swiss Med Wkly; 2015 Jun 01; 145():w14043. PubMed ID: 25588018
    [Abstract] [Full Text] [Related]

  • 5. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P, Hołownia P, Kapka-Skrzypczak L, Wojtyła A.
    Ann Agric Environ Med; 2012 Jun 01; 19(4):857-70. PubMed ID: 23311820
    [Abstract] [Full Text] [Related]

  • 6. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G, Hurst D, Penn A, Yung K.
    Mil Med; 2012 Sep 01; 177(9):1041-8. PubMed ID: 23025133
    [Abstract] [Full Text] [Related]

  • 7. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.
    Rosenbaum CD, Carreiro SP, Babu KM.
    J Med Toxicol; 2012 Mar 01; 8(1):15-32. PubMed ID: 22271566
    [Abstract] [Full Text] [Related]

  • 8. Novel Psychoactive Substances and Trends of Abuse.
    Rivera JV, Vance EG, Rushton WF, Arnold JK.
    Crit Care Nurs Q; 2017 Mar 01; 40(4):374-382. PubMed ID: 28834859
    [Abstract] [Full Text] [Related]

  • 9. Analytical toxicology of emerging drugs of abuse--an update.
    Meyer MR, Peters FT.
    Ther Drug Monit; 2012 Dec 01; 34(6):615-21. PubMed ID: 23131695
    [Abstract] [Full Text] [Related]

  • 10. Designer drugs 2015: assessment and management.
    Weaver MF, Hopper JA, Gunderson EW.
    Addict Sci Clin Pract; 2015 Mar 25; 10(1):8. PubMed ID: 25928069
    [Abstract] [Full Text] [Related]

  • 11. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL, Gerona RR, Horowitz BZ, Vian KP, Troxell ML, Hendrickson RG, Houghton DC, Rozansky D, Su SW, Leman RF.
    Clin Toxicol (Phila); 2014 Aug 25; 52(7):664-73. PubMed ID: 25089722
    [Abstract] [Full Text] [Related]

  • 12. Novel psychoactive substances.
    Krabseth HM, Tuv SS, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Øiestad EL, Vindenes V.
    Tidsskr Nor Laegeforen; 2016 May 25; 136(8):714-7. PubMed ID: 27143461
    [Abstract] [Full Text] [Related]

  • 13. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L, Petit A, Cottencin O, Coscas S, Reynaud M.
    Rev Prat; 2012 May 25; 62(5):664-6. PubMed ID: 22730798
    [Abstract] [Full Text] [Related]

  • 14. Emerging drugs of abuse.
    Nelson ME, Bryant SM, Aks SE.
    Emerg Med Clin North Am; 2014 Feb 25; 32(1):1-28. PubMed ID: 24275167
    [Abstract] [Full Text] [Related]

  • 15. Emerging drugs of abuse: clinical and legal considerations.
    Aoun EG, Christopher PP, Ingraham JW.
    R I Med J (2013); 2014 Jun 02; 97(6):41-5. PubMed ID: 24905374
    [Abstract] [Full Text] [Related]

  • 16. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Platteborze PL, Martin TM.
    Mil Med; 2013 Jan 02; 178(1):v. PubMed ID: 23356108
    [No Abstract] [Full Text] [Related]

  • 17. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM, Valente MJ, Carvalho M, Dias da Silva D, Gaspar H, Carvalho F, de Lourdes Bastos M, Guedes de Pinho P.
    Arch Toxicol; 2015 May 02; 89(5):757-71. PubMed ID: 24903018
    [Abstract] [Full Text] [Related]

  • 18. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
    Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P.
    Clin Toxicol (Phila); 2011 Mar 02; 49(3):131-41. PubMed ID: 21495881
    [Abstract] [Full Text] [Related]

  • 19. New drugs of abuse.
    Rech MA, Donahey E, Cappiello Dziedzic JM, Oh L, Greenhalgh E.
    Pharmacotherapy; 2015 Feb 02; 35(2):189-97. PubMed ID: 25471045
    [Abstract] [Full Text] [Related]

  • 20. Khat and synthetic cathinones: a review.
    Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M.
    Arch Toxicol; 2014 Jan 02; 88(1):15-45. PubMed ID: 24317389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.